UF Researchers Get Closer to Saliva Test for Breast Cancer
UF researchers have improved a potentially transformative handheld device to detect breast cancer in saliva, simplifying the design and confirming its accuracy.
Research Snapshot: Genetic Score Shows Promise in Improving Leukemia Outcomes
UF researchers have found that a genetic score holds promise for improving treatment results in patients with acute myeloid leukemia (AML) who have traditionally had poor outcomes by allowing chemotherapy regimens to be personalized.
Applying AI to Cancer Research, a UF Professor Helps Transform Medical Imaging
UF researchers are developing AI algorithms for a range of medical image analysis tasks, such as multimodal image fusion, cancer detection, organ segmentation, and enhanced image resolution for diagnosis.
Eat Better, Breathe Easier? Research Points To Link Between Diet, Lung Cancer
UF researchers have found that poor diet may influence lung cancer risk, challenging traditional views on diet-related diseases.
Dr. Fan Zhang Named UF Health Cancer Center Rising Star of the Year
UF researcher Fan Zhang, Ph.D., an assistant professor of pharmaceutics at the University of Florida, has been named a 2025 recipient of the UF Health Cancer Center Rising Star of the Year Award.
UF Study of Deadly Dog Cancer Reveals New Clues for Improved Treatment
UF researchers have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.
Research Snapshot: Researchers Identify Genes That Predict Pediatric AML Outcomes
UF researchers identified genes that were associated with resistance or sensitivity to chemotherapy and linked these with patients’ treatment outcomes.
Yoga Program May Reduce Depression and Anxiety in Women With Cancer
UF researchers have found that a program combining yoga and psychological tools in a group therapy setting may help reduce symptoms of depression and anxiety in women with certain common cancers.
UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder
UF Health has become one of only 40 VHL Alliance Clinical Care Centers in the United States.
The VHL Alliance is made up of leading healthcare organizations that specialize in treating von Hippel-Lindau (VHL) syndrome, a rare inherited disorder associated with tumors.
Hans Shuhaiber, M.D., a clinical assistant professor in the department of neurology in the UF College of Medicine and a member of the UF Health Cancer Center, said this recognition will ensure patients have access to the best treatment when they come to UF Health.
Dr. Castillo Caro Accepted into Early Investigator Advancement Program
Paul Castillo, M.D., was recently accepted into the National Cancer Institute’s Early Investigator Advancement Program. The program aims to bolster expertise and offer guidance for investigators to create competitive grant applications.